Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      FTC Warns PBM Practices Are Driving Higher Drug Costs and Employers Start to Push Back


      News provided by

      US-Rx

      Mar 02, 2026, 08:13 ET

      Share this article

      Share this article


      This year, a combination of rising pharmacy costs and increased regulatory risk has led to a tipping point for the PBM industry. In the face of regulatory scrutiny and litigation, US-Rx Care CEO Renzo Luzzatti believes that employers cannot wait for government intervention to change in the industry.

      TAMARAC, Fla., March 2, 2026 /PRNewswire/ -- US-Rx Care, the nation's first fiduciary pharmacy risk manager and an industry leader since 2007, is issuing an urgent strategic call-out to employers: the Pharmacy Benefit Manager (PBM) industry has reached a point of no return. After years of hidden incentives, conflicts of interest, and complex revenue models, mounting federal audits, fiduciary litigation, and expanding state regulations are dismantling the industry's long-standing "opacity premium."

      Continue Reading
      "It starts with changing how you purchase pharmacy benefit services and demanding fiduciary accountability. Employers can take control today by moving to a fiduciary PBM model that eliminates conflicts of interest and aligns plan management with the best interests of plan and members."
      "It starts with changing how you purchase pharmacy benefit services and demanding fiduciary accountability. Employers can take control today by moving to a fiduciary PBM model that eliminates conflicts of interest and aligns plan management with the best interests of plan and members."

      These forces make 2026 more than just another year of policy debate. They mark a structural shift where employer governance and market pressure converge to force reform. US-Rx Care advises plan sponsors that they can no longer rely on traditional PBM contracting models and must proactively move to fiduciary standards to stabilize financial and regulatory risk.

      "Employers should be asking: Why are we seeing an uptick in government involvement at the federal and state level?" said Renzo Luzzatti, co-founder and CEO of US-Rx Care. "The answer is that this is a broken system. The PBM industry has operated for too long with hidden incentives and too little accountability. It has become deeply problematic. That is why regulators are stepping in and why employers are demanding real change."

      The "Opacity Premium" Collapses as Employers Become Investigators

      For decades, employer-sponsored plans quietly financed the U.S. prescription drug system. That purchasing behavior is now changing. Plan sponsors are shifting from passive acceptance of PBM terms to active verification and accountability.

      As federal regulators demand greater disclosure of drug-level economics, formulary decisions, and conflicts of interest, employers must recognize their own ERISA-defined fiduciary obligations. The Federal Trade Commission has documented how major PBMs extract value through pricing and steering dynamics that prioritize profit over affordability for plans and patients.

      As these legacy revenue models face regulatory and legal pressure, the traditional PBM sector will likely enter a period of contract renegotiation and structural adjustment. That transition creates volatility for employers locked into opaque contracts.

      "What's happening now will force major changes to the traditional PBM revenue model," Luzzatti stated. "They will likely have to re-contract everything. The real question is: where will hidden margins be captured going forward, and what will the impact be on plan management and patients?"

      Litigation and Regulation Force a Fiduciary Power Shift

      This structural shift is accelerated by external pressures that are turning pharmacy benefits from an administrative function into a board-level fiduciary responsibility. The discussion has moved beyond price negotiation to duty of care, disclosure, and enforceable accountability.

      • Fiduciary Pressure Changes the Dynamic. Employers are increasingly being held accountable for the performance of their health plans. The Consolidated Appropriations Act and expanding ERISA enforcement make clear that generalized assurances of "lowest net cost" are insufficient. Plan sponsors must demand contractual commitments and measurable proof that their PBM acts in the best interest of the plan and its members.
      • Litigation Is Accelerating Reform. High-profile lawsuits against major corporations for breaches of fiduciary duty in health benefit oversight have become a wake-up call. These cases highlight the risks of relying on conflicted advisors and opaque pricing structures. Litigation is removing the plausible deniability that allowed the flawed system to persist.
      • States Are a Laboratory for Reform: While federal debate continues, states including Arkansas, Florida, and California are taking direct action. Aggressive regulatory measures are challenging PBM practices and eliminating traditional revenue strategies. This momentum signals a more restrictive environment ahead for legacy PBMs.

      Together, these developments move PBM reform from policy discussion to fiduciary reality. Employers must align accordingly in 2026 and beyond.

      Luzzatti cautions against waiting for government action to fix it all. "Will the government eliminate all conflicts of interest from the PBM industry? Can oversight alone fix a broken system and force true fiduciary alignment?" He said. "While there is a lot in the news about PBM reform, employers do not need to wait for regulators to solve a decades-old problem. They can act now."

      The Inevitability of the Fiduciary Model

      As the market confronts this structural reset, US-Rx Care's fiduciary PBM model is no longer a niche alternative. It is becoming the baseline standard for financial and compliance risk management. The narrative is shifting from optional transparency to fiduciary accountability, a higher and legally enforceable standard. The solution to the PBM crisis is not legislative. It is contractual.

      US-Rx Care provides employers with a conflict-free model that eliminates pharmacy ownership, operates on a 100 percent pass-through basis for discounts and rebates, and charges a transparent administrative fee. This structure offers operational clarity and fiscal alignment at a time of industry disruption.

      "The solution is already available," Luzzatti concluded. "It starts with changing how you purchase pharmacy benefit services and demanding fiduciary accountability. Employers can take control today by moving to a fiduciary PBM model that eliminates conflicts of interest and aligns plan management with the best interests of plan and members. While regulatory wheels turn at the federal and state level, plan sponsors do not have to wait."

      About US-Rx Care 
      US-Rx Care is revolutionizing America's pharmacy benefits system by replacing opaque, profit-driven PBMs with a fiduciary model that puts employers and members first. Founded in 2007, the company combines clinical rigor, ethical contracting, and data-driven oversight to cut drug costs by up to 50% or more while also improving health outcomes. Operating under a legally binding ERISA fiduciary standard, US-Rx Care eliminates conflicts of interest, passes through 100% of manufacturer rebates and pharmacy discounts, and delivers measurable savings without compromising care. Privately owned and free from outside financial influence, US-Rx Care is setting the new standard for pharmacy benefit management—restoring trust, accountability, and real control for employers, benefits consultants, and health plans nationwide.  To learn more, visit www.us-rxcare.com.

      References: 

      Benefits Law Advisor (Jan. 15, 2026): Proposed Legislation to Make PBMs ERISA Fiduciaries and Disclose Compensation benefitslawadvisor.com/2026/01/articles/pbm/proposed-legislation-to-make-pbms-erisa-fiduciaries-and-disclose-compensation/ 

      Federal Trade Commission (Jan. 14, 2025): FTC Releases Second Interim Staff Report on Prescription Drug Middlemen (PBMs). ftc.gov/news-events/news/press-releases/2025/01/ftc-releases-second-interim-staff-report-prescription-drug-middlemen 

      FTC Report (Jan. 2025): Specialty Generic Drugs: A Growing Profit Center for Vertically Integrated PBMs. ftc.gov/reports/specialty-generic-drugs-growing-profit-center-vertically-integrated-pharmacy-benefit-managers 

      AP News (Apr. 2025): Arkansas bans pharmacy benefit managers from owning pharmacies in state. apnews.com/article/9e2449a2ac7f7aa206cd49f9211447b3 

      Axios (Jun. 9, 2025): PBM trade group sues Arkansas over pharmacy law. axios.com/2025/06/09/arkansas-pharmacy-law-pbm 

      PharmaVoice (Jun. 16, 2025): Locked in a federal stalemate, states take PBM reform into their own hands. pharmavoice.com/news/federal-drug-pricing-state-pbm-reform-arkansas-ban/750726/ 

      National Law Review / Mintz (May 6, 2025): Arkansas Law Takes Unprecedented Step to Prohibit PBM Ownership of Pharmacies. natlawreview.com/article/arkansas-law-takes-unprecedented-step-prohibit-pbm-ownership-pharmacies 

      Congress.gov: PBM Reform Act of 2025 (bill text). congress.gov/bill/119th-congress/house-bill/4317/text/ih 

      Media Inquiries:  
      Karla Jo Helms  
      JOTO PR™ 
      727-777-4629 
      Jotopr.com 

      SOURCE US-Rx

      Modal title

      Also from this source

      Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions

      Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions

      Employer pharmacy costs are rising faster than healthcare costs overall. Business Group on Health estimates drug costs will increase 12% in 2026,...

      Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics

      Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics

      Employers have spent decades chasing bigger discounts and richer rebates in PBM bids. Yet pharmacy costs keep rising. According to US-Rx Care, many...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.